世界の吸入抗感染症薬市場レポート、歴史と予測2018-2029年、メーカー別内訳データ、主要地域別、タイプ別、用途別Global Inhaled Anti-Infectives Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application QYResearch社の調査レポート「吸入抗感染症薬」は、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。世界の吸入抗感染症薬市場は、2022年の3億8,200万米ドルから202... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーQYResearch社の調査レポート「吸入抗感染症薬」は、COVID-19とロシア・ウクライナ戦争が2022年の市場に二重の影響を与えることを明らかにしている。世界の吸入抗感染症薬市場は、2022年の3億8,200万米ドルから2029年には6億3,650万米ドルに達すると予測され、2023年から2029年までの年平均成長率は5.6%である。病院薬局と小売薬局からの需要が業界の主な促進要因である。世界の医薬品市場は2022年に1,475億ドルに達し、今後6年間のCAGRは5%で成長する。医薬品市場には、化学医薬品と生物学的製剤が含まれる。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要とする患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19パンデミックはワクチン開発とサプライチェーン・マネジメントの重要性を浮き彫りにし、製薬企業が公衆衛生の新たなニーズに機敏に対応する必要性をさらに強調している。 レポートの範囲 本レポートは、過去の分析(2018-2022年)と予測計算(2023-2029年)に基づき、読者が世界の吸入抗感染症薬市場を多角的に包括的に理解し、読者の戦略と意思決定に十分な支援を提供することを目的としています。 レポートに掲載されているメーカー、タイプ、用途、地域 企業別 アストラゼネカ ジョンソン・エンド・ジョンソン グラクソ・スミスクライン ノバルティスAG ファイザー ウォックハルト ロシュ サノフィ メルク タイプ別セグメント エアゾール ドライパウダー製剤 スプレー 用途別セグメント 病院薬局 小売薬局 オンライン薬局 地域別セグメント 北米 米国 カナダ 欧州 ドイツ フランス イギリス イタリア ロシア アジア太平洋 中国 日本 韓国 インド オーストラリア 台湾 インドネシア タイ マレーシア フィリピン ベトナム ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 本レポートの各章は、読者が吸入抗感染症薬市場をさらに理解するための詳細な情報を提供します: 第1章:2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品定義、製品タイプ、各タイプの販売量および収益分析。 第2章:売上高と収益の比較を含むメーカーの競争状況、吸入抗感染薬のメーカーの商業日、各メーカーが提供する製品タイプ、M&A活動、吸入抗感染薬業界で発生した拡張活動。 第3章:北米、欧州、アジア太平洋、ラテンアメリカ、中東、アフリカにおける吸入抗感染症の過去(2018-2022年)および予測(2023-2029年)の数量と収益分析。 第4章:2018年から2023年までの北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカにおける製品用途、各用途の数量および収益分析。 第5章から第9章:北米、欧州、アジア太平洋、ラテンアメリカ、中東およびアフリカの国別レベル分析、数量および収益分析を含む。 第10章:メーカーの概要、本社、連絡先、主要事業、吸入抗感染症薬の紹介などの企業の基本情報をカバーする。また、各社の売上高、収益、価格、グロスマージン、最近の動向もこの部分に含まれています。 第11章:原材料、製造コストのような産業チェーンがカバーされています。加えて、市場機会と課題もこの章で強調されている。 第12章:市場チャネル、流通業者と顧客がリストアップされています。 第13章包括的な調査に基づくQYResearchの吸入抗感染症薬市場の結論。 第14章:QYResearchが採用した方法論とデータソース。 目次1 Inhaled Anti-Infectives Market Overview1.1 Inhaled Anti-Infectives Product Overview 1.2 Inhaled Anti-Infectives Market Segment by Type 1.2.1 Aerosol 1.2.2 Dry Powder Formulation 1.2.3 Spray 1.3 Global Inhaled Anti-Infectives Market Size by Type 1.3.1 Global Inhaled Anti-Infectives Market Size Overview by Type (2018-2029) 1.3.2 Global Inhaled Anti-Infectives Historic Market Size Review by Type (2018-2023) 1.3.3 Global Inhaled Anti-Infectives Forecasted Market Size by Type (2024-2029) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023) 1.4.2 Europe Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023) 1.4.3 Asia-Pacific Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023) 1.4.4 Latin America Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023) 1.4.5 Middle East and Africa Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023) 2 Global Inhaled Anti-Infectives Market Competition by Company 2.1 Global Top Players by Inhaled Anti-Infectives Sales (2018-2023) 2.2 Global Top Players by Inhaled Anti-Infectives Revenue (2018-2023) 2.3 Global Top Players by Inhaled Anti-Infectives Price (2018-2023) 2.4 Global Top Manufacturers Inhaled Anti-Infectives Manufacturing Base Distribution, Sales Area, Product Type 2.5 Inhaled Anti-Infectives Market Competitive Situation and Trends 2.5.1 Inhaled Anti-Infectives Market Concentration Rate (2018-2023) 2.5.2 Global 5 and 10 Largest Manufacturers by Inhaled Anti-Infectives Sales and Revenue in 2022 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inhaled Anti-Infectives as of 2022) 2.7 Date of Key Manufacturers Enter into Inhaled Anti-Infectives Market 2.8 Key Manufacturers Inhaled Anti-Infectives Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Inhaled Anti-Infectives Status and Outlook by Region 3.1 Global Inhaled Anti-Infectives Market Size and CAGR by Region: 2018 VS 2022 VS 2029 3.2 Global Inhaled Anti-Infectives Historic Market Size by Region 3.2.1 Global Inhaled Anti-Infectives Sales in Volume by Region (2018-2023) 3.2.2 Global Inhaled Anti-Infectives Sales in Value by Region (2018-2023) 3.2.3 Global Inhaled Anti-Infectives Sales (Volume & Value) Price and Gross Margin (2018-2023) 3.3 Global Inhaled Anti-Infectives Forecasted Market Size by Region 3.3.1 Global Inhaled Anti-Infectives Sales in Volume by Region (2024-2029) 3.3.2 Global Inhaled Anti-Infectives Sales in Value by Region (2024-2029) 3.3.3 Global Inhaled Anti-Infectives Sales (Volume & Value), Price and Gross Margin (2024-2029) 4 Global Inhaled Anti-Infectives by Application 4.1 Inhaled Anti-Infectives Market Segment by Application 4.1.1 Hospital Pharmacies 4.1.2 Retail Pharmacies 4.1.3 Online Pharmacies 4.2 Global Inhaled Anti-Infectives Market Size by Application 4.2.1 Global Inhaled Anti-Infectives Market Size Overview by Application (2018-2029) 4.2.2 Global Inhaled Anti-Infectives Historic Market Size Review by Application (2018-2023) 4.2.3 Global Inhaled Anti-Infectives Forecasted Market Size by Application (2024-2029) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023) 4.3.2 Europe Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023) 4.3.3 Asia-Pacific Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023) 4.3.4 Latin America Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023) 4.3.5 Middle East and Africa Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023) 5 North America Inhaled Anti-Infectives by Country 5.1 North America Inhaled Anti-Infectives Historic Market Size by Country 5.1.1 North America Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 5.1.2 North America Inhaled Anti-Infectives Sales in Volume by Country (2018-2023) 5.1.3 North America Inhaled Anti-Infectives Sales in Value by Country (2018-2023) 5.2 North America Inhaled Anti-Infectives Forecasted Market Size by Country 5.2.1 North America Inhaled Anti-Infectives Sales in Volume by Country (2024-2029) 5.2.2 North America Inhaled Anti-Infectives Sales in Value by Country (2024-2029) 6 Europe Inhaled Anti-Infectives by Country 6.1 Europe Inhaled Anti-Infectives Historic Market Size by Country 6.1.1 Europe Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 6.1.2 Europe Inhaled Anti-Infectives Sales in Volume by Country (2018-2023) 6.1.3 Europe Inhaled Anti-Infectives Sales in Value by Country (2018-2023) 6.2 Europe Inhaled Anti-Infectives Forecasted Market Size by Country 6.2.1 Europe Inhaled Anti-Infectives Sales in Volume by Country (2024-2029) 6.2.2 Europe Inhaled Anti-Infectives Sales in Value by Country (2024-2029) 7 Asia-Pacific Inhaled Anti-Infectives by Region 7.1 Asia-Pacific Inhaled Anti-Infectives Historic Market Size by Region 7.1.1 Asia-Pacific Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029 7.1.2 Asia-Pacific Inhaled Anti-Infectives Sales in Volume by Region (2018-2023) 7.1.3 Asia-Pacific Inhaled Anti-Infectives Sales in Value by Region (2018-2023) 7.2 Asia-Pacific Inhaled Anti-Infectives Forecasted Market Size by Region 7.2.1 Asia-Pacific Inhaled Anti-Infectives Sales in Volume by Region (2024-2029) 7.2.2 Asia-Pacific Inhaled Anti-Infectives Sales in Value by Region (2024-2029) 8 Latin America Inhaled Anti-Infectives by Country 8.1 Latin America Inhaled Anti-Infectives Historic Market Size by Country 8.1.1 Latin America Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 8.1.2 Latin America Inhaled Anti-Infectives Sales in Volume by Country (2018-2023) 8.1.3 Latin America Inhaled Anti-Infectives Sales in Value by Country (2018-2023) 8.2 Latin America Inhaled Anti-Infectives Forecasted Market Size by Country 8.2.1 Latin America Inhaled Anti-Infectives Sales in Volume by Country (2024-2029) 8.2.2 Latin America Inhaled Anti-Infectives Sales in Value by Country (2024-2029) 9 Middle East and Africa Inhaled Anti-Infectives by Country 9.1 Middle East and Africa Inhaled Anti-Infectives Historic Market Size by Country 9.1.1 Middle East and Africa Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 9.1.2 Middle East and Africa Inhaled Anti-Infectives Sales in Volume by Country (2018-2023) 9.1.3 Middle East and Africa Inhaled Anti-Infectives Sales in Value by Country (2018-2023) 9.2 Middle East and Africa Inhaled Anti-Infectives Forecasted Market Size by Country 9.2.1 Middle East and Africa Inhaled Anti-Infectives Sales in Volume by Country (2024-2029) 9.2.2 Middle East and Africa Inhaled Anti-Infectives Sales in Value by Country (2024-2029) 10 Company Profiles 10.1 Astra Zeneca 10.1.1 Astra Zeneca Company Information 10.1.2 Astra Zeneca Introduction and Business Overview 10.1.3 Astra Zeneca Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.1.4 Astra Zeneca Inhaled Anti-Infectives Products Offered 10.1.5 Astra Zeneca Recent Development 10.2 Johnson &Johnson 10.2.1 Johnson &Johnson Company Information 10.2.2 Johnson &Johnson Introduction and Business Overview 10.2.3 Johnson &Johnson Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.2.4 Johnson &Johnson Inhaled Anti-Infectives Products Offered 10.2.5 Johnson &Johnson Recent Development 10.3 Glaxo SmithKline 10.3.1 Glaxo SmithKline Company Information 10.3.2 Glaxo SmithKline Introduction and Business Overview 10.3.3 Glaxo SmithKline Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.3.4 Glaxo SmithKline Inhaled Anti-Infectives Products Offered 10.3.5 Glaxo SmithKline Recent Development 10.4 Novartis AG 10.4.1 Novartis AG Company Information 10.4.2 Novartis AG Introduction and Business Overview 10.4.3 Novartis AG Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.4.4 Novartis AG Inhaled Anti-Infectives Products Offered 10.4.5 Novartis AG Recent Development 10.5 Pfizer 10.5.1 Pfizer Company Information 10.5.2 Pfizer Introduction and Business Overview 10.5.3 Pfizer Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.5.4 Pfizer Inhaled Anti-Infectives Products Offered 10.5.5 Pfizer Recent Development 10.6 Wockhardt 10.6.1 Wockhardt Company Information 10.6.2 Wockhardt Introduction and Business Overview 10.6.3 Wockhardt Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.6.4 Wockhardt Inhaled Anti-Infectives Products Offered 10.6.5 Wockhardt Recent Development 10.7 Roche 10.7.1 Roche Company Information 10.7.2 Roche Introduction and Business Overview 10.7.3 Roche Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.7.4 Roche Inhaled Anti-Infectives Products Offered 10.7.5 Roche Recent Development 10.8 Sanofi 10.8.1 Sanofi Company Information 10.8.2 Sanofi Introduction and Business Overview 10.8.3 Sanofi Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.8.4 Sanofi Inhaled Anti-Infectives Products Offered 10.8.5 Sanofi Recent Development 10.9 Merck 10.9.1 Merck Company Information 10.9.2 Merck Introduction and Business Overview 10.9.3 Merck Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.9.4 Merck Inhaled Anti-Infectives Products Offered 10.9.5 Merck Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Inhaled Anti-Infectives Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Inhaled Anti-Infectives Industrial Chain Analysis 11.4 Inhaled Anti-Infectives Market Dynamics 11.4.1 Inhaled Anti-Infectives Industry Trends 11.4.2 Inhaled Anti-Infectives Market Drivers 11.4.3 Inhaled Anti-Infectives Market Challenges 11.4.4 Inhaled Anti-Infectives Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Inhaled Anti-Infectives Distributors 12.3 Inhaled Anti-Infectives Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer
SummaryInhaled Anti-Infectives report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Inhaled Anti-Infectives market is projected to reach US$ 636.5 million in 2029, increasing from US$ 382 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry. Table of Contents1 Inhaled Anti-Infectives Market Overview1.1 Inhaled Anti-Infectives Product Overview 1.2 Inhaled Anti-Infectives Market Segment by Type 1.2.1 Aerosol 1.2.2 Dry Powder Formulation 1.2.3 Spray 1.3 Global Inhaled Anti-Infectives Market Size by Type 1.3.1 Global Inhaled Anti-Infectives Market Size Overview by Type (2018-2029) 1.3.2 Global Inhaled Anti-Infectives Historic Market Size Review by Type (2018-2023) 1.3.3 Global Inhaled Anti-Infectives Forecasted Market Size by Type (2024-2029) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023) 1.4.2 Europe Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023) 1.4.3 Asia-Pacific Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023) 1.4.4 Latin America Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023) 1.4.5 Middle East and Africa Inhaled Anti-Infectives Sales Breakdown by Type (2018-2023) 2 Global Inhaled Anti-Infectives Market Competition by Company 2.1 Global Top Players by Inhaled Anti-Infectives Sales (2018-2023) 2.2 Global Top Players by Inhaled Anti-Infectives Revenue (2018-2023) 2.3 Global Top Players by Inhaled Anti-Infectives Price (2018-2023) 2.4 Global Top Manufacturers Inhaled Anti-Infectives Manufacturing Base Distribution, Sales Area, Product Type 2.5 Inhaled Anti-Infectives Market Competitive Situation and Trends 2.5.1 Inhaled Anti-Infectives Market Concentration Rate (2018-2023) 2.5.2 Global 5 and 10 Largest Manufacturers by Inhaled Anti-Infectives Sales and Revenue in 2022 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Inhaled Anti-Infectives as of 2022) 2.7 Date of Key Manufacturers Enter into Inhaled Anti-Infectives Market 2.8 Key Manufacturers Inhaled Anti-Infectives Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Inhaled Anti-Infectives Status and Outlook by Region 3.1 Global Inhaled Anti-Infectives Market Size and CAGR by Region: 2018 VS 2022 VS 2029 3.2 Global Inhaled Anti-Infectives Historic Market Size by Region 3.2.1 Global Inhaled Anti-Infectives Sales in Volume by Region (2018-2023) 3.2.2 Global Inhaled Anti-Infectives Sales in Value by Region (2018-2023) 3.2.3 Global Inhaled Anti-Infectives Sales (Volume & Value) Price and Gross Margin (2018-2023) 3.3 Global Inhaled Anti-Infectives Forecasted Market Size by Region 3.3.1 Global Inhaled Anti-Infectives Sales in Volume by Region (2024-2029) 3.3.2 Global Inhaled Anti-Infectives Sales in Value by Region (2024-2029) 3.3.3 Global Inhaled Anti-Infectives Sales (Volume & Value), Price and Gross Margin (2024-2029) 4 Global Inhaled Anti-Infectives by Application 4.1 Inhaled Anti-Infectives Market Segment by Application 4.1.1 Hospital Pharmacies 4.1.2 Retail Pharmacies 4.1.3 Online Pharmacies 4.2 Global Inhaled Anti-Infectives Market Size by Application 4.2.1 Global Inhaled Anti-Infectives Market Size Overview by Application (2018-2029) 4.2.2 Global Inhaled Anti-Infectives Historic Market Size Review by Application (2018-2023) 4.2.3 Global Inhaled Anti-Infectives Forecasted Market Size by Application (2024-2029) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023) 4.3.2 Europe Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023) 4.3.3 Asia-Pacific Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023) 4.3.4 Latin America Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023) 4.3.5 Middle East and Africa Inhaled Anti-Infectives Sales Breakdown by Application (2018-2023) 5 North America Inhaled Anti-Infectives by Country 5.1 North America Inhaled Anti-Infectives Historic Market Size by Country 5.1.1 North America Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 5.1.2 North America Inhaled Anti-Infectives Sales in Volume by Country (2018-2023) 5.1.3 North America Inhaled Anti-Infectives Sales in Value by Country (2018-2023) 5.2 North America Inhaled Anti-Infectives Forecasted Market Size by Country 5.2.1 North America Inhaled Anti-Infectives Sales in Volume by Country (2024-2029) 5.2.2 North America Inhaled Anti-Infectives Sales in Value by Country (2024-2029) 6 Europe Inhaled Anti-Infectives by Country 6.1 Europe Inhaled Anti-Infectives Historic Market Size by Country 6.1.1 Europe Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 6.1.2 Europe Inhaled Anti-Infectives Sales in Volume by Country (2018-2023) 6.1.3 Europe Inhaled Anti-Infectives Sales in Value by Country (2018-2023) 6.2 Europe Inhaled Anti-Infectives Forecasted Market Size by Country 6.2.1 Europe Inhaled Anti-Infectives Sales in Volume by Country (2024-2029) 6.2.2 Europe Inhaled Anti-Infectives Sales in Value by Country (2024-2029) 7 Asia-Pacific Inhaled Anti-Infectives by Region 7.1 Asia-Pacific Inhaled Anti-Infectives Historic Market Size by Region 7.1.1 Asia-Pacific Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029 7.1.2 Asia-Pacific Inhaled Anti-Infectives Sales in Volume by Region (2018-2023) 7.1.3 Asia-Pacific Inhaled Anti-Infectives Sales in Value by Region (2018-2023) 7.2 Asia-Pacific Inhaled Anti-Infectives Forecasted Market Size by Region 7.2.1 Asia-Pacific Inhaled Anti-Infectives Sales in Volume by Region (2024-2029) 7.2.2 Asia-Pacific Inhaled Anti-Infectives Sales in Value by Region (2024-2029) 8 Latin America Inhaled Anti-Infectives by Country 8.1 Latin America Inhaled Anti-Infectives Historic Market Size by Country 8.1.1 Latin America Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 8.1.2 Latin America Inhaled Anti-Infectives Sales in Volume by Country (2018-2023) 8.1.3 Latin America Inhaled Anti-Infectives Sales in Value by Country (2018-2023) 8.2 Latin America Inhaled Anti-Infectives Forecasted Market Size by Country 8.2.1 Latin America Inhaled Anti-Infectives Sales in Volume by Country (2024-2029) 8.2.2 Latin America Inhaled Anti-Infectives Sales in Value by Country (2024-2029) 9 Middle East and Africa Inhaled Anti-Infectives by Country 9.1 Middle East and Africa Inhaled Anti-Infectives Historic Market Size by Country 9.1.1 Middle East and Africa Inhaled Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029 9.1.2 Middle East and Africa Inhaled Anti-Infectives Sales in Volume by Country (2018-2023) 9.1.3 Middle East and Africa Inhaled Anti-Infectives Sales in Value by Country (2018-2023) 9.2 Middle East and Africa Inhaled Anti-Infectives Forecasted Market Size by Country 9.2.1 Middle East and Africa Inhaled Anti-Infectives Sales in Volume by Country (2024-2029) 9.2.2 Middle East and Africa Inhaled Anti-Infectives Sales in Value by Country (2024-2029) 10 Company Profiles 10.1 Astra Zeneca 10.1.1 Astra Zeneca Company Information 10.1.2 Astra Zeneca Introduction and Business Overview 10.1.3 Astra Zeneca Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.1.4 Astra Zeneca Inhaled Anti-Infectives Products Offered 10.1.5 Astra Zeneca Recent Development 10.2 Johnson &Johnson 10.2.1 Johnson &Johnson Company Information 10.2.2 Johnson &Johnson Introduction and Business Overview 10.2.3 Johnson &Johnson Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.2.4 Johnson &Johnson Inhaled Anti-Infectives Products Offered 10.2.5 Johnson &Johnson Recent Development 10.3 Glaxo SmithKline 10.3.1 Glaxo SmithKline Company Information 10.3.2 Glaxo SmithKline Introduction and Business Overview 10.3.3 Glaxo SmithKline Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.3.4 Glaxo SmithKline Inhaled Anti-Infectives Products Offered 10.3.5 Glaxo SmithKline Recent Development 10.4 Novartis AG 10.4.1 Novartis AG Company Information 10.4.2 Novartis AG Introduction and Business Overview 10.4.3 Novartis AG Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.4.4 Novartis AG Inhaled Anti-Infectives Products Offered 10.4.5 Novartis AG Recent Development 10.5 Pfizer 10.5.1 Pfizer Company Information 10.5.2 Pfizer Introduction and Business Overview 10.5.3 Pfizer Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.5.4 Pfizer Inhaled Anti-Infectives Products Offered 10.5.5 Pfizer Recent Development 10.6 Wockhardt 10.6.1 Wockhardt Company Information 10.6.2 Wockhardt Introduction and Business Overview 10.6.3 Wockhardt Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.6.4 Wockhardt Inhaled Anti-Infectives Products Offered 10.6.5 Wockhardt Recent Development 10.7 Roche 10.7.1 Roche Company Information 10.7.2 Roche Introduction and Business Overview 10.7.3 Roche Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.7.4 Roche Inhaled Anti-Infectives Products Offered 10.7.5 Roche Recent Development 10.8 Sanofi 10.8.1 Sanofi Company Information 10.8.2 Sanofi Introduction and Business Overview 10.8.3 Sanofi Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.8.4 Sanofi Inhaled Anti-Infectives Products Offered 10.8.5 Sanofi Recent Development 10.9 Merck 10.9.1 Merck Company Information 10.9.2 Merck Introduction and Business Overview 10.9.3 Merck Inhaled Anti-Infectives Sales, Revenue and Gross Margin (2018-2023) 10.9.4 Merck Inhaled Anti-Infectives Products Offered 10.9.5 Merck Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Inhaled Anti-Infectives Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Inhaled Anti-Infectives Industrial Chain Analysis 11.4 Inhaled Anti-Infectives Market Dynamics 11.4.1 Inhaled Anti-Infectives Industry Trends 11.4.2 Inhaled Anti-Infectives Market Drivers 11.4.3 Inhaled Anti-Infectives Market Challenges 11.4.4 Inhaled Anti-Infectives Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Inhaled Anti-Infectives Distributors 12.3 Inhaled Anti-Infectives Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(データ解析)の最新刊レポートQYResearch 社の最新刊レポート本レポートと同じKEY WORD(breakdown data)の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/04 10:27 147.72 円 163.39 円 196.69 円 |